These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27576071)

  • 21. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
    Harada Y; Ninomiya-Mori A; Takahashi Y; Shirakura M; Kishida N; Kageyama T; Tada Y; Tashiro M; Odagiri T
    Vaccine; 2011 Oct; 29(46):8330-7. PubMed ID: 21911027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin.
    Alexander J; Ward S; Mendy J; Manayani DJ; Farness P; Avanzini JB; Guenther B; Garduno F; Jow L; Snarsky V; Ishioka G; Dong X; Vang L; Newman MJ; Mayall T
    PLoS One; 2012; 7(2):e31177. PubMed ID: 22363572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.
    Vemula SV; Amen O; Katz JM; Donis R; Sambhara S; Mittal SK
    Virus Res; 2013 Dec; 178(2):398-403. PubMed ID: 24051000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
    Wang G; Zhou F; Buchy P; Zuo T; Hu H; Liu J; Song Y; Ding H; Tsai C; Chen Z; Zhang L; Deubel V; Zhou P
    J Infect Dis; 2014 Mar; 209(5):676-85. PubMed ID: 23911711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a New Viral Vaccine Vector in Mice and Rhesus Macaques: J Paramyxovirus Expressing Hemagglutinin of Influenza A Virus H5N1.
    Abraham M; Beavis AC; Xiao P; Villinger FJ; Li Z; Jones CA; Tompkins SM; He B
    J Virol; 2021 Oct; 95(22):e0132121. PubMed ID: 34469242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection.
    Zou Z; Hu Y; Liu Z; Zhong W; Cao H; Chen H; Jin M
    Vet Res; 2015 Apr; 46(1):42. PubMed ID: 25889564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge.
    Kingstad-Bakke B; Kamlangdee A; Osorio JE
    Vaccine; 2015 Sep; 33(39):5155-62. PubMed ID: 26271828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C
    Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus.
    Lu Y; Landreth S; Liu G; Brownlie R; Gaba A; Littel-van den Hurk SVD; Gerdts V; Zhou Y
    Vaccine; 2020 Feb; 38(10):2387-2395. PubMed ID: 32014270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge.
    Liu G; Zhang F; Shi J; Tian G; Chen H; Yu K; Meng Q
    Vaccine; 2013 Nov; 31(46):5398-404. PubMed ID: 24055355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.
    Cox F; Baart M; Huizingh J; Tolboom J; Dekking L; Goudsmit J; Saeland E; Radošević K
    PLoS One; 2015; 10(12):e0145243. PubMed ID: 26696245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.
    Kodihalli S; Goto H; Kobasa DL; Krauss S; Kawaoka Y; Webster RG
    J Virol; 1999 Mar; 73(3):2094-8. PubMed ID: 9971791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
    He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
    Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).
    Sipo I; Knauf M; Fechner H; Poller W; Planz O; Kurth R; Norley S
    Vaccine; 2011 Feb; 29(8):1690-9. PubMed ID: 21195079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
    Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ
    Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice.
    Kim EH; Han GY; Nguyen H
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses.
    Lin SC; Liu WC; Lin YF; Huang YH; Liu JH; Wu SC
    Biotechnol J; 2013 Nov; 8(11):1315-22. PubMed ID: 23813782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.
    Prabakaran M; Kolpe AB; He F; Kwang J
    Vaccine; 2013 Feb; 31(10):1385-92. PubMed ID: 23328313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.